Molecular Pathphysiology of FSHD muscular dystrophy via genome-wide approaches
通过全基因组方法研究 FSHD 肌营养不良症的分子病理生理学
基本信息
- 批准号:7209944
- 负责人:
- 金额:$ 35.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-15 至 2012-02-28
- 项目状态:已结题
- 来源:
- 关键词:4q35AdultAffectAgeAnimal ModelAnteriorApoptosisAppearanceBelgiumBindingBinding SitesBiochemicalBiological AssayBiopsyCandidate Disease GeneCellsChromosomesClinicalComputer softwareConsensusCreatine KinaseD4Z4DataDermatomyositisDevelopmentDiseaseDisease modelDoxycyclineDuchenne muscular dystrophyEMSAEmbryonic DevelopmentEmbryonic and Fetal DevelopmentEvaluationFaceFacioscapulohumeralFacioscapulohumeral Muscular DystrophyFibroblastsFunctional disorderFutureGene ExpressionGene Expression RegulationGene TargetingGenesGeneticGenetic TranscriptionGenomeGoalsHindlimbHomeoboxHomeostasisHomologous GeneIn VitroInflammationInheritedLifeLimb DevelopmentLimb structureLocationLong-Term EffectsLower ExtremityLuciferasesMediatingMessenger RNAModelingMolecularMolecular ProfilingMolecular TargetMonitorMusMuscleMuscle FibersMuscle WeaknessMuscular AtrophyMuscular DystrophiesMutagenesisMutationMyoblastsMyopathyNatural regenerationNeuromuscular DiseasesOnset of illnessOxidative StressPathogenesisPathway interactionsPatientsPhenotypePhosphotransferasesPlayPredispositionPrincipal InvestigatorProcessPromoter RegionsReporterReporter GenesResearchResearch PersonnelReverse Transcriptase Polymerase Chain ReactionRoleSeriesSerumShoulderSiblingsSiteSkeletal MuscleSpinalStagingTestingTetanus Helper PeptideTetracyclineTetracyclinesTimeTinTranscriptional ActivationTransgenic MiceTransgenic ModelTransgenic OrganismsTriceps Brachii MuscleUbiquitinUniversitiesUp-RegulationUpper armWeekbasechromatin immunoprecipitationdayderepressiondisease phenotypeexpression vectorfusion genegene functiongene inductiongene interactionhomeobox protein PITX1homeodomainin vivoinjuredmouse genomemouse modelmulticatalytic endopeptidase complexpostnatalprogramspromoterresearch studyresponsesextranscription factortransgene expressionvectorwasting
项目摘要
DESCRIPTION (provided by applicant): Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant muscle disorder that is characterized by the progressive weakness and wasting of the muscles from face, upper-arm and shoulder girdle to lower limb. While there is consensus that FSHD is a disorder of transcription and gene regulation, the molecular pathways leading to muscular dystrophy and other unique clinical features of the disease are far from clear. Our preliminary study of whole genome profiles of 125 muscle biopsies representing 12 neuromuscular disorders showed that paired-like homeodomain transcription factor 1 (PITX1) gene was specifically up-regulated in FSHD patients. The significant PITX1 over-expression we observed in FSHD can not be due to inflammation, degeneration/ regeneration, or other "dystrophic" changes in muscle, as no other muscle disease (including juvenile dermatomyositis, Duchenne dystrophy, and others) showed up- regulation. Based on our extensive preliminary data both in vitro and in vivo, we present a model where over-expression of PITX1 in adult muscle invokes key muscle atrophy pathways, and, further, that PITX1 is regulated by DUX4 expression. The goal of this current proposal is to further develop our pathophysiological model to show direct relationships between 4q35 deletions, DUX4, and PITX1. The proposed research relies heavily on temporal series, conducted both in vivo and in vitro. Gene/gene interactions will also be determined. In aim 1, we propose to determine if Pitxl is a direct target of DUX4. We will determine whether a putative DUX4 binding site in the promoter region of Pitxl is functional, and whether it is specifically and directly regulated by DUX4. Additional DUX4 targets will be identified by temporal profiling. Interaction between DUX4 and potential target genes will be determined. In aim 2, we propose to generate and characterize a conditional muscle-specific Pitxl transgenic mouse model. The phenotype will be evaluated for changes in various clinical, functional, biochemical, molecular, and histological parameters. The phenotype of myoblasts, including appearance, proliferation, differentiation and susceptibility to oxidative stress, will also be evaluated. In addition, we will determine whether the disease phenotype is reversible. In aim 3, we will define molecular transcriptional pathways downstream of Pitxl expression using the Pitxl transgenic mouse. Temporal expression profiling will be performed to construct the pathways regulated by Pitxl. Interactions between Pitxl and potential regulatory targets of Pitxl will be further studied. Our preliminary data showed that disease-specific up-regulation of DUX4 and Pitxl and downstream changes of genes involved in muscle wasting might be involved in the pathophysiology of FSHD. The proposed research will identify key players in the pathological cascades of FSHD and define the interactions among them, which could potentially be used for developing treatments of the disease.
描述(由申请人提供):Faciosculohumeral肌肉营养不良(FSHD)是一种常染色体显性肌肉障碍,其特征是逐渐无力和从脸部,上臂和肩膀束缚到下肢的肌肉。尽管有共识,即FSHD是一种转录和基因调节障碍,但导致肌肉营养不良的分子途径和该疾病的其他独特临床特征远非明显。我们对代表125种神经肌肉疾病的125个肌肉活检的整个基因组轮廓的初步研究表明,在FSHD患者中,对成对的类同源域转录因子1(PITX1)基因特别上调。我们在FSHD中观察到的明显的PITX1过表达不可能是由于炎症,变性/再生或其他肌肉中的其他“营养不良”变化,因为没有其他肌肉疾病(包括其他肌肉疾病(包括少年性皮肤肌炎,杜氏肌疾病症状疾病,其他营养不良症等))表现出了调节。基于我们在体外和体内的广泛初步数据,我们提出了一个模型,其中Pitx1在成人肌肉中的过表达会引起关键的肌肉萎缩途径,此外,PITX1受DUX4表达的调节。当前建议的目的是进一步发展我们的病理生理模型,以显示4q35缺失,DUX4和PITX1之间的直接关系。拟议的研究在很大程度上依赖于时间序列,在体内和体外进行了。基因/基因相互作用也将得到确定。在AIM 1中,我们建议确定PITXL是否是DUX4的直接目标。我们将确定PITXL启动子区域中的假定DUX4结合位点功能是否功能,以及它是否由DUX4进行了专门和直接调节。其他DUX4目标将通过时间分析确定。将确定DUX4与潜在靶基因之间的相互作用。在AIM 2中,我们建议生成和表征有条件的肌肉特异性PITXL转基因小鼠模型。将评估表型的各种临床,功能,生化,分子和组织学参数的变化。还将评估成肌细胞的表型,包括外观,增殖,分化和对氧化应激的敏感性。此外,我们将确定疾病表型是否可逆。在AIM 3中,我们将使用PITXL转基因小鼠在PITXL表达下游的分子转录途径。将进行时间表达分析以构建由PITXL调节的途径。将进一步研究PITXL与PITXL潜在调节目标之间的相互作用。我们的初步数据表明,DUX4和PITXL的疾病特异性上调以及涉及肌肉浪费的基因的下游变化可能与FSHD的病理生理有关。拟议的研究将在FSHD的病理级联中确定关键参与者,并定义它们之间的相互作用,这些相互作用有可能用于开发疾病的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YI-WEN CHEN其他文献
YI-WEN CHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YI-WEN CHEN', 18)}}的其他基金
Investigating proteostasis in facioscapulohumeral muscular dystrophy
研究面肩肱型肌营养不良症的蛋白质稳态
- 批准号:
10430945 - 财政年份:2022
- 资助金额:
$ 35.69万 - 项目类别:
Investigating proteostasis in facioscapulohumeral muscular dystrophy
研究面肩肱型肌营养不良症的蛋白质稳态
- 批准号:
10652315 - 财政年份:2022
- 资助金额:
$ 35.69万 - 项目类别:
Investigating membrane repair capacity in facioscapulohumeral muscular dystrophy
研究面肩肱型肌营养不良症的膜修复能力
- 批准号:
10365948 - 财政年份:2021
- 资助金额:
$ 35.69万 - 项目类别:
A Long-read Sequencing Approach for Investigating Repeat Number and DNA Methylation of the D4Z4 Region
用于研究 D4Z4 区域重复数和 DNA 甲基化的长读长测序方法
- 批准号:
10093171 - 财政年份:2020
- 资助金额:
$ 35.69万 - 项目类别:
Characterizing a Conditional Transgenic Mouse Model of FSHD
FSHD 条件转基因小鼠模型的表征
- 批准号:
8845224 - 财政年份:2014
- 资助金额:
$ 35.69万 - 项目类别:
Molecular Pathphysiology of FSHD muscular dystrophy via genome-wide approaches
通过全基因组方法研究 FSHD 肌营养不良症的分子病理生理学
- 批准号:
8073308 - 财政年份:2010
- 资助金额:
$ 35.69万 - 项目类别:
Molecular Pathphysiology of FSHD muscular dystrophy via genome-wide approaches
通过全基因组方法研究 FSHD 肌营养不良症的分子病理生理学
- 批准号:
7817383 - 财政年份:2009
- 资助金额:
$ 35.69万 - 项目类别:
Molecular Pathphysiology of FSHD muscular dystrophy via genome-wide approaches
通过全基因组方法研究 FSHD 肌营养不良症的分子病理生理学
- 批准号:
7569419 - 财政年份:2007
- 资助金额:
$ 35.69万 - 项目类别:
Molecular Pathphysiology of FSHD muscular dystrophy via genome-wide approaches
通过全基因组方法研究 FSHD 肌营养不良症的分子病理生理学
- 批准号:
7383818 - 财政年份:2007
- 资助金额:
$ 35.69万 - 项目类别:
Molecular Pathphysiology of FSHD muscular dystrophy via genome-wide approaches
通过全基因组方法研究 FSHD 肌营养不良症的分子病理生理学
- 批准号:
7772306 - 财政年份:2007
- 资助金额:
$ 35.69万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
Accessible FSHD diagnostics through epigenetic analysis
通过表观遗传分析进行 FSHD 诊断
- 批准号:
10556422 - 财政年份:2022
- 资助金额:
$ 35.69万 - 项目类别:
Accessible FSHD diagnostics through epigenetic analysis
通过表观遗传分析进行 FSHD 诊断
- 批准号:
10391097 - 财政年份:2022
- 资助金额:
$ 35.69万 - 项目类别:
Mechanisms of DUX4 mediated FSHD pathology
DUX4 介导的 FSHD 病理机制
- 批准号:
9288155 - 财政年份:2017
- 资助金额:
$ 35.69万 - 项目类别:
Pathogenic Mechanisms in Facioscapulohumeral Muscular Dystrophy
面肩肱型肌营养不良症的发病机制
- 批准号:
9277391 - 财政年份:2016
- 资助金额:
$ 35.69万 - 项目类别:
Mechanisms of DUX4 mediated FSHD pathology
DUX4 介导的 FSHD 病理机制
- 批准号:
10554358 - 财政年份:2013
- 资助金额:
$ 35.69万 - 项目类别: